PMA device
Crystalens and Trulign Toric Intraocular Lenses (Iols)
Bausch & Lomb, Inc. · Lens, Intraocular, Toric Optics (MJP, Class III) · First FDA decision Feb 9, 2016, newest Mar 24, 2016Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
8
Naming "Crystalens"
MAUDE reports
592
Brand "Crystalens", since 2015
PubMed studies
57
Mentioning "Crystalens"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Crystalens and Trulign Toric Intraocular Lenses (Iols)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- CRYSTALENS AND TRULIGN TORIC INTRAOCULAR LENSES (IOLS)PMA supplement
P030002-S035 · Decided Mar 24, 2016 · 266 days after receipt · Normal 180 Day Track No User Fee
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
P030002-S037 · Decided Feb 9, 2016 · 53 days after receipt · Normal 180 Day Track No User Fee
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Crystalens", any status and sponsor, newest update first.
Bausch & Lomb IncorporatedNot on our public-company list
NCT01241279 · 6 participants · Start Oct 2010 · Primary completion Nov 2011
Device: Crystalens AO; SoftPort LI61AO · For: Cataract
Sites: Irvine, California
- Toric Intraocular Lens Following Cataract SurgeryPivotal-lookingCompleted
Bausch & Lomb IncorporatedNot on our public-company list
NCT01140477 · 229 participants · Start Jun 2010 · Primary completion Dec 2011
Device: Toric Accommodating Lens; Accommodating Lens · For: Cataract; Astigmatism
Sites: Bridgewater, New Jersey
Bausch & Lomb IncorporatedNot on our public-company list
NCT01122576 · 78 participants · Start Jun 2010 · Primary completion Jun 2012
Device: Crystalens AO; ReSTOR and 1 more · For: Cataract
Sites: Aliso Viejo, California
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Crystalens", and for the whole product code for context.
This brand
592 reports: 2 malfunction, 588 injury, 0 death
Whole product code MJP
7,937 reports: 3,518 malfunction, 4,419 injury, 0 death
Newest reports for this brand
- CRYSTALENSOther
MW5181593 · Received Jan 2, 2026 · Event dated May 9, 2024
Device type: Lens, Intraocular, Accommodative (NAA)
Patient problem as coded: Scar Tissue; Visual Impairment
0001313525-2024-00128 · Received Jul 25, 2024 · Event dated May 9, 2024
Device type: Lens, Intraocular, Accommodative (NAA)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Capsular Contracture; Blurred Vision; Posterior Capsule Opacification
0001313525-2023-70104 · Received Sep 1, 2023 · Event dated Aug 24, 2017
Device type: Lens, Intraocular, Accommodative (NAA)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Capsular Contracture; Blurred Vision; Halo
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0445-2012 · Started Nov 14, 2011 · Posted by FDA Jan 11, 2012
Reason given: Bausch + Lomb voluntary initiated the recall due to a physician complaint of haze on the Crystalens AO which was visualized using an angled beam from a slit lamp during the post-operative examination.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Lens, Intraocular, Accommodative (NAA)
Published research
The most relevant PubMed records for "Crystalens"[tiab]. The summary above synthesizes these.
- CRYSTALENS REPOSITIONING WITH SCLERAL SUTURE TECHNIQUE.
Smiddy WE · Retin Cases Brief Rep · 2023
- A prospective randomized clinical evaluation of 3 presbyopia-correcting intraocular lenses after cataract extraction.
Pepose JS, Qazi MA, Chu R, et al. · Am J Ophthalmol · 2014Comparative Study, Multicenter Study
- Prospective evaluation of visual outcomes with three presbyopia-correcting intraocular lenses following cataract surgery.
Ang R, Martinez G, Cruz E, et al. · Clin Ophthalmol · 2013
- Benefits and barriers of accommodating intraocular lenses.
Pepose JS, Burke J, Qazi MA · Curr Opin Ophthalmol · 2017Review
- Visual outcomes after accommodating intraocular lens implantation.
Macsai MS, Padnick-Silver L, Fontes BM · J Cataract Refract Surg · 2006Comparative Study, Multicenter Study
- Aberrometry in patients implanted with accommodative intraocular lenses.
Pérez-Merino P, Birkenfeld J, Dorronsoro C, et al. · Am J Ophthalmol · 2014Observational Study, Research Support, Non-U.S. Gov't
- Crystalens HD intraocular lens analysis using an adaptive optics visual simulator.
Pérez-Vives C, Montés-Micó R, López-Gil N, et al. · Optom Vis Sci · 2013Research Support, Non-U.S. Gov't
- Accommodative intraocular lenses: current status.
Dick HB · Curr Opin Ophthalmol · 2005Review
- Lens exchange for management of accommodative intraocular lens tilting.
Mohebbi M, Afshan AB, Inanloo B, et al. · Taiwan J Ophthalmol · 2019Case Reports
- A NOVEL SURGICAL TECHNIQUE FOR RESCUING A DISLOCATED ACCOMMODATIVE INTRAOCULAR LENS (CRYSTALENS).
Mantopoulos D, Prenner JL, Wheatley HM · Retin Cases Brief Rep · 2021Case Reports
- Clinical evaluation of the Crystalens AT-45 accommodating intraocular lens: results of the U.S. Food and Drug Administration clinical trial.
Cumming JS, Colvard DM, Dell SJ, et al. · J Cataract Refract Surg · 2006Clinical Trial, Phase II, Multicenter Study
- Visual performance of patients with bilateral vs combination Crystalens, ReZoom, and ReSTOR intraocular lens implants.
Pepose JS, Qazi MA, Davies J, et al. · Am J Ophthalmol · 2007Comparative Study, Controlled Clinical Trial
Other devices of this type
Also filed under product code MJP.
- TECNIS Toric 1-Piece Intraocular Lenses (IOL)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- Trulign Toric Posterior Chamber Intraocular LensBausch & Lomb, Inc. · PMA 2015
- enVista One-Piece Hydrophobic Acrylic Toric Intraocular Lens (Model MX60T)Bausch & Lomb, Inc. · PMA 2018
- Crystalens Accommodating Intraocular Lens & Trulign Toric Intraocular LensBausch & Lomb, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.